✦ LIBER ✦

Identification, Optimization, and Pharmacology of Acylurea GHS-R1a Inverse Agonists

✍ Scribed by McCoull, William; Barton, Peter; Brown, Alastair J. H.; Bowker, Suzanne S.; Cameron, Jennifer; Clarke, David S.; Davies, Robert D. M.; Dossetter, Alexander G.; Ertan, Anne; Fenwick, Mark; Green, Clive; Holmes, Jane L.; Martin, Nathaniel; Masters, David; Moore, Jane E.; Newcombe, Nicholas J.; Newton, Claire; Pointon, Helen; Robb, Graeme R.; Sheldon, Christopher; Stokes, Stephen; Morgan, David

Book ID: 125504630
Publisher: American Chemical Society
Year: 2014
Tongue: English
Weight: 843 KB
Volume: 57
Category: Article
ISSN: 0022-2623
DOI: 10.1021/jm500610n

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Identification of pyrazolo-pyrimidinones

Identification of pyrazolo-pyrimidinones as GHS-R1a antagonists and inverse agonists for the treatment of obesity

✍ McCoull, William; Barton, Peter; Broo, Anders; Brown, Alastair J. H.; Clarke, Da 📂 Article 📅 2013 🏛 The Royal Society of Chemistry 🌐 English ⚖ 374 KB

GHRP-2, a GHS-R agonist, directly acts o

GHRP-2, a GHS-R agonist, directly acts on myocytes to attenuate the dexamethasone-induced expressions of muscle-specific ubiquitin ligases, Atrogin-1 and MuRF1

✍ Daisuke Yamamoto; Nobuko Ikeshita; Takako Matsubara; Hiromitsu Tasaki; Elizabeth 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 489 KB

Identification, Characterization and Pha

Identification, Characterization and Pharmacological Profile of Three Metabolites of (R)-(+)-1,2,3,6-Tetrahydro-4-phenyl-1-[(3-phenylcyclohexen-1-yl)methyl]p yridine (CI-1007), a Dopamine Autoreceptor Agonist and Potential Antipsychotic Agent

✍ Wright, Jon L.; Downing, Dennis M.; Feng, M. Rose; Hayes, Roger N.; Heffner, Tho 📂 Article 📅 1995 🏛 American Chemical Society 🌐 English ⚖ 927 KB

Structure–affinity relationships and pha

Structure–affinity relationships and pharmacological characterization of new alkyl-resorcinol cannabinoid receptor ligands: Identification of a dual cannabinoid receptor/TRPA1 channel agonist

✍ Brizzi, Antonella; Aiello, Francesca; Marini, Pietro; Cascio, Maria Grazia; Core 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 744 KB

A clinical trial assessing the safety an

A clinical trial assessing the safety and efficacy of taranabant, a CB1R inverse agonist, in obese and overweight patients: a high-dose study

✍ Aronne, L J; Tonstad, S; Moreno, M; Gantz, I; Erondu, N; Suryawanshi, S; Molony, 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 711 KB

A clinical trial assessing the safety an

A clinical trial assessing the safety and efficacy of the CB1R inverse agonist taranabant in obese and overweight patients: low-dose study

✍ Proietto, J; Rissanen, A; Harp, J B; Erondu, N; Yu, Q; Suryawanshi, S; Jones, M 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 494 KB